SCHEMBL21881790

SCHEMBL21881790

c1ccc(-c2ncnc(-c3cccc(-c4cccc(-c5cc(-c6ccccc6)c(-c6ccccc6)c(-c6ccccc6)c5-c5ccccc5)c4)c3)n2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GP6 Q9HCN6 1/20 0.35
KMO O15229 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.34
MEN1 O00255 3/20 0.33
ALDH1A1 P00352 3/20 0.33
MAPT P10636 3/20 0.33
HPGD P15428 3/20 0.33
KMT2A Q03164 3/20 0.33
CSF1R P07333 1/20 0.33
PDGFRB P09619 1/20 0.33
GSK3A P49840 1/20 0.33
CDK9 P50750 1/20 0.33
CDK5 Q00535 1/20 0.33
ACVR1 Q04771 1/20 0.33
CDK5R1 Q15078 1/20 0.33
TAOK1 Q7L7X3 1/20 0.33
DYRK1B Q9Y463 1/20 0.33
KDM4E B2RXH2 2/20 0.33
LMNA P02545 2/20 0.33
GLA P06280 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21881793 0.98 L3MBTL1 (0.35) GP6KMOL3MBTL1MEN1ALDH1A1
SCHEMBL29500541 0.90 L3MBTL1 (0.42) GP6L3MBTL1MEN1ALDH1A1MAPT
SCHEMBL21881792 0.90 MEN1 (0.41) L3MBTL1MEN1ALDH1A1MAPTHPGD
SCHEMBL31624102 0.90 L3MBTL1 (0.42) GP6L3MBTL1MEN1ALDH1A1MAPT
SCHEMBL18180999 0.90 L3MBTL1 (0.42) GP6L3MBTL1MEN1ALDH1A1MAPT
SCHEMBL18180975 0.90 L3MBTL1 (0.42) GP6L3MBTL1MEN1ALDH1A1MAPT
SCHEMBL20080954 0.89 L3MBTL1 (0.41) GP6KMOL3MBTL1MEN1ALDH1A1
SCHEMBL20080971 0.89 L3MBTL1 (0.41) GP6KMOL3MBTL1MEN1ALDH1A1
SCHEMBL19497364 0.89 L3MBTL1 (0.41) GP6KMOL3MBTL1MEN1ALDH1A1
SCHEMBL31453997 0.89 L3MBTL1 (0.41) GP6KMOL3MBTL1MEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11795186-B2 Organic electronic device comprising an organic semiconductor layer and a device NOVALED GMBH (DE) 2023-10-24 US disclosed
US-11795186-B2 Organic electronic device comprising an organic semiconductor layer and a device NOVALED GMBH (DE) 2023-10-24 US disclosed
US-20200161559-A1 Organic Electronic Device Comprising an Organic Semiconductor Layer NOVALED GMBH (DE) 2020-05-21 US disclosed
US-20200095269-A1 Organic Electronic Device Comprising an Organic Semiconductor Layer and a Device NOVALED GMBH (DE) 2020-03-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200095269-A1 Organic Electronic Device Comprising an Organic Semiconductor Layer and a Device C1S, C1R, CCNA1 GP6 1041/4885KMO 1436/4885L3MBTL1 812/4885
US-11795186-B2 Organic electronic device comprising an organic semiconductor layer and a device C1S, C1R, CCNA1 GP6 1041/4885KMO 1436/4885L3MBTL1 812/4885
US-20200161559-A1 Organic Electronic Device Comprising an Organic Semiconductor Layer C1S, YAP1, ESR1 GP6 2995/4885KMO 1941/4885L3MBTL1 710/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.